Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes: An Overview of Data from PROactive
Year: 2009
Type: review
Source: Drug Safety
Institutions: St George's Hospital, Takeda (United Kingdom)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: pioglitazone, type 2 diabetes, PROactive trial, macrovascular events, secondary prevention of cardiovascular disease, tolerability, edema, weight gain, hypoglycemia, heart failure, liver function tests, hepatic steatosis, cancer risk, bladder cancer, breast cancer, bone fractures, adverse drug reactions
Open Access status: closed
OpenAlex ID: W1999225509
